Tags

Type your tag names separated by a space and hit enter

Continuous dopaminergic therapy in Parkinson disease: time to stride back?
Ann Neurol. 2010 Jul; 68(1):3-5.AN

Authors

No affiliation info available

Pub Type(s)

Comment
Editorial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20583222

Citation

Stoessl, A Jon. "Continuous Dopaminergic Therapy in Parkinson Disease: Time to Stride Back?" Annals of Neurology, vol. 68, no. 1, 2010, pp. 3-5.
Stoessl AJ. Continuous dopaminergic therapy in Parkinson disease: time to stride back? Ann Neurol. 2010;68(1):3-5.
Stoessl, A. J. (2010). Continuous dopaminergic therapy in Parkinson disease: time to stride back? Annals of Neurology, 68(1), 3-5. https://doi.org/10.1002/ana.22079
Stoessl AJ. Continuous Dopaminergic Therapy in Parkinson Disease: Time to Stride Back. Ann Neurol. 2010;68(1):3-5. PubMed PMID: 20583222.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Continuous dopaminergic therapy in Parkinson disease: time to stride back? A1 - Stoessl,A Jon, PY - 2010/6/29/entrez PY - 2010/6/29/pubmed PY - 2010/7/21/medline SP - 3 EP - 5 JF - Annals of neurology JO - Ann Neurol VL - 68 IS - 1 SN - 1531-8249 UR - https://www.unboundmedicine.com/medline/citation/20583222/Continuous_dopaminergic_therapy_in_Parkinson_disease:_time_to_stride_back L2 - https://doi.org/10.1002/ana.22079 DB - PRIME DP - Unbound Medicine ER -